| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +53.5% |
| R&D Expense | $36.9M | +117.8% |
| SG&A Expense | $7.3M | +13.4% |
| Operating Income | -$42.7M | -90.7% |
| Net Income | -$42.2M | -88.9% |
| EPS (Basic) | -$3.77 | -54.5% |
| EPS (Diluted) | -$3.77 | -54.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.1M | +119.8% |
| Accounts Receivable | $0 | — |
| Current Assets | $24.4M | +91.2% |
| Total Assets | $26.8M | +77.3% |
| Current Liabilities | $33.3M | +48.6% |
| Total Liabilities | $39.9M | +67.7% |
| Stockholders' Equity | -$13.1M | -51.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.9M | -12.0% |
| Capital Expenditures | $530K | +44.4% |
| Investing Cash Flow | -$530K | -44.4% |
| Financing Cash Flow | $34.7M | +300.1% |
| Free Cash Flow | -$23.5M | -12.6% |